119 related articles for article (PubMed ID: 12963061)
21. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D.
Yasuda Y; Kageyama T; Akamine A; Shibata M; Kominami E; Uchiyama Y; Yamamoto K
J Biochem; 1999 Jun; 125(6):1137-43. PubMed ID: 10348917
[TBL] [Abstract][Full Text] [Related]
22. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG; Willenbrock F; Murphy G
FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
[TBL] [Abstract][Full Text] [Related]
23. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Lauer-Fields JL; Tuzinski KA; Shimokawa Ki; Nagase H; Fields GB
J Biol Chem; 2000 May; 275(18):13282-90. PubMed ID: 10788434
[TBL] [Abstract][Full Text] [Related]
24. Structural consequences of D-amino acids in collagen triple-helical peptides.
Shah NK; Brodsky B; Kirkpatrick A; Ramshaw JA
Biopolymers; 1999 Apr; 49(4):297-302. PubMed ID: 10079768
[TBL] [Abstract][Full Text] [Related]
25. Using fluorogenic peptide substrates to assay matrix metalloproteinases.
Fields GB
Methods Mol Biol; 2010; 622():393-433. PubMed ID: 20135296
[TBL] [Abstract][Full Text] [Related]
26. Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates.
Ermolieff J; Loy JA; Koelsch G; Tang J
Biochemistry; 2000 Oct; 39(40):12450-6. PubMed ID: 11015226
[TBL] [Abstract][Full Text] [Related]
27. Assays of matrix metalloproteinases (MMPs) activities: a review.
Lombard C; Saulnier J; Wallach J
Biochimie; 2005; 87(3-4):265-72. PubMed ID: 15781313
[TBL] [Abstract][Full Text] [Related]
28. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
[TBL] [Abstract][Full Text] [Related]
29. Development of a Förster resonance energy transfer assay for monitoring bacterial collagenase triple-helical peptidase activity.
Tokmina-Roszyk M; Tokmina-Roszyk D; Bhowmick M; Fields GB
Anal Biochem; 2014 May; 453():61-9. PubMed ID: 24608089
[TBL] [Abstract][Full Text] [Related]
30. A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Bickett DM; Green MD; Berman J; Dezube M; Howe AS; Brown PJ; Roth JT; McGeehan GM
Anal Biochem; 1993 Jul; 212(1):58-64. PubMed ID: 8368516
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
32. Enhanced cleavage of diaminopimelate-containing isopeptides by leucine aminopeptidase and matrix metalloproteinases in tumors: application to bioadhesive peptides.
Yamazaki Y; Savva M; Kleinman HK; Oka S; Mokotoff M
J Pept Res; 1999 Feb; 53(2):177-87. PubMed ID: 10195455
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
[TBL] [Abstract][Full Text] [Related]
34. Continuously recording fluorescent assays optimized for five human matrix metalloproteinases.
Netzel-Arnett S; Mallya SK; Nagase H; Birkedal-Hansen H; Van Wart HE
Anal Biochem; 1991 May; 195(1):86-92. PubMed ID: 1888020
[TBL] [Abstract][Full Text] [Related]
35. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
[TBL] [Abstract][Full Text] [Related]
36. Cyclotriveratrylene (CTV) as a new chiral triacid scaffold capable of inducing triple helix formation of collagen peptides containing either a native sequence or Pro-Hyp-Gly repeats.
Rump ET; Rijkers DT; Hilbers HW; de Groot PG; Liskamp RM
Chemistry; 2002 Oct; 8(20):4613-21. PubMed ID: 12362398
[TBL] [Abstract][Full Text] [Related]
37. Exosite interactions impact matrix metalloproteinase collagen specificities.
Robichaud TK; Steffensen B; Fields GB
J Biol Chem; 2011 Oct; 286(43):37535-42. PubMed ID: 21896477
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.
Lively TJ; Bosco DB; Khamis ZI; Sang QX
Methods Mol Biol; 2016; 1406():161-70. PubMed ID: 26820953
[TBL] [Abstract][Full Text] [Related]
39. A high throughput fluorogenic substrate for stromelysin (MMP-3).
Bickett DM; Green MD; Wagner C; Roth JT; Berman J; McGeehan GM
Ann N Y Acad Sci; 1994 Sep; 732():351-5. PubMed ID: 7978805
[TBL] [Abstract][Full Text] [Related]
40. Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11.
Knapinska AM; Hart M; Drotleff G; Fields GB
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
